ENDOCYTE INC
DelistedCIK 1235007fmd_0Q00K5YY32HDRV3FV5AR1KYMDPManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2018, 35 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 3 | 0 | 0 | 35 | 65 | 70 | 0 | 0 | 0 |
| Net interest income | – | – | – | – | 0 | 1 | 1 | – | – |
| Research and development | 15 | 15 | 29 | 36 | 58 | 42 | 26 | 27 | 26 |
| Total operating expenses | 19 | 21 | 39 | 51 | 83 | 65 | 42 | 45 | 56 |
| Operating income | (16) | (21) | (39) | (16) | (18) | 5 | (42) | (45) | (56) |
| Interest expense | 1 | 1 | 2 | 1 | 0 | 0 | – | – | – |
| Interest and investment income | 0 | 0 | 0 | 0 | 0 | 1 | – | – | – |
| Other non-operating income (expense) | – | 2 | (0) | (1) | (0) | (0) | 0 | (0) | 0 |
| Net income | (17) | (20) | (41) | (17) | (18) | 5 | (41) | (44) | (55) |